Cy3 Goat Anti-Human IgG (H+L) Antibody: Advancing Immunofluorescence Precision

Principle and Setup: Harnessing the Power of Cy3 Fluorescence

The Cy3 Goat Anti-Human IgG (H+L) Antibody is engineered as a fluorescent secondary antibody for human IgG detection, offering robust sensitivity and versatility across immunofluorescence assay (IFA), immunohistochemistry (IHC), flow cytometry, and ELISA. This affinity-purified, polyclonal goat anti-human IgG is conjugated with the Cy3 dye, boasting an excitation at 552 nm and emission at 565 nm, ensuring strong and stable fluorescence signals even in demanding multiplexed assays.

The antibody is produced by immunizing goats with pooled human immunoglobulins, followed by immunoaffinity purification using antigen-coupled agarose beads. This meticulous process yields a reagent with high specificity for human IgG (heavy and light chains), minimizing cross-reactivity and background noise. The result: an optimal blend of sensitivity and selectivity, crucial for applications where subtle differences in human immunoglobulin levels must be detected with confidence.

In the context of translational immunology and infectious disease research—such as the recent characterization of anti-M1R and anti-B6R antibodies for orthopoxvirus protection (Zhao et al., 2025)—the need for precise, quantifiable detection of human IgG is paramount. The Cy3 Goat Anti-Human IgG (H+L) Antibody addresses this by amplifying signal intensity through multiple secondary antibody bindings per primary, thus enhancing assay sensitivity and linearity.

Step-by-Step Workflow: Protocol Enhancements for Major Assay Formats

1. Immunofluorescence and Immunocytochemistry (IF/ICC)

• Sample Preparation: Fix cells with 4% paraformaldehyde and permeabilize with 0.1% Triton X-100 to ensure antibody access to intracellular targets.
• Blocking: Incubate with 1% BSA in PBS for 30 minutes to reduce nonspecific binding.
• Primary Antibody Incubation: Apply human IgG-specific primary antibody at a validated dilution (typically 1:100–1:500) for 1 hour at room temperature.
• Secondary Antibody Labelling: Add Cy3 Goat Anti-Human IgG (H+L) Antibody at 1–2 μg/mL; incubate for 45–60 minutes protected from light.
• Washing and Mounting: Wash thoroughly with PBS and mount with anti-fade medium.

Performance insights: In benchmarked workflows (see here), the Cy3 conjugated secondary antibody consistently delivers signal-to-noise ratios exceeding 15:1, even at low antigen abundance, outperforming conventional Alexa Fluor 555 conjugates in side-by-side comparisons.

2. Immunohistochemistry (IHC) on Frozen and Paraffin-Embedded Tissues

• Sectioning: For paraffin-embedded samples, deparaffinize in xylene and rehydrate through graded alcohols; for frozen, fix with acetone or PFA.
• Antigen Retrieval (if needed): Perform citrate buffer boiling for 10–20 minutes.
• Blocking and Primary/Secondary Incubation: As above, using Cy3 Goat Anti-Human IgG (H+L) Antibody at 1–3 μg/mL.
• Counterstaining: Apply DAPI for nuclear visualization if desired.

Optimization tip: Protect sections from light post-secondary incubation to maintain Cy3 fluorescence integrity.

3. Flow Cytometry

• Cell Staining: Block Fc receptors with normal goat serum (5–10%) to reduce background.
• Primary/Secondary Staining: Incubate live or fixed cells with human IgG primary, then Cy3 Goat Anti-Human IgG (H+L) Antibody (0.5–1 μg/test).
• Wash and Analyze: Wash thoroughly and analyze with a 561 nm laser, collecting emission at 570 nm.

Quantified advantage: In validated flow cytometry antibody panels, the Cy3 secondary provided up to 1.7× higher median fluorescence intensity (MFI) than FITC-conjugated alternatives, as reported in multiplexing strategy analyses (resource here).

4. ELISA

• Plate Coating: Coat with antigen or capture antibody overnight at 4°C.
• Blocking: Block with 5% BSA in PBS for 1 hour.
• Sample and Detection: Incubate with sample, followed by human IgG primary and Cy3 Goat Anti-Human IgG (H+L) Antibody (0.5–2 μg/mL).
• Readout: Measure fluorescence on a plate reader with 550 nm excitation, 570 nm emission.

For quantitative immunoglobulin detection, this ELISA secondary antibody achieves a linear dynamic range spanning 2–3 orders of magnitude, supporting both diagnostic and research-grade quantification.

Advanced Applications and Comparative Advantages

Multiplexing and Translational Immunology: The Cy3 Goat Anti-Human IgG (H+L) Antibody excels in multiplexed assays due to its spectral separation from other commonly used fluorophores (e.g., FITC, Cy5), enabling simultaneous detection of multiple analytes. This capacity is critical in studies such as the orthopoxvirus antibody mapping by Zhao et al. (2025), where parallel profiling of immune responses demands both sensitivity and selectivity.

Signal Amplification in Immunoassays: By binding multiple secondary antibodies to each primary, the Cy3 conjugated format can increase fluorescence output up to 4–6-fold over directly labeled primaries, supporting the detection of low-abundance targets—an imperative in early-stage infection or biomarker discovery workflows (see mechanistic analysis).

Reliability and Reproducibility: APExBIO’s rigorous manufacturing and quality control, coupled with the antibody’s 12-month stability at -20°C, minimize lot-to-lot variation. This reliability is vital for multi-center studies and high-throughput screening, as highlighted in this workflow optimization resource, which demonstrates consistent assay linearity and reproducibility over 50+ independent runs.

Comparison with Alternatives: While alternatives like Alexa Fluor, DyLight, or FITC-conjugated secondaries offer broad utility, Cy3’s robust photostability and bright emission profile provide superior performance in applications where signal decay or spectral overlap is a concern.

Troubleshooting and Optimization Tips

• Weak or No Signal: Verify the integrity and concentration of primary and Cy3 secondary antibody solutions. Avoid repeated freeze-thaw cycles by aliquoting upon first use. Ensure samples have been adequately fixed and permeabilized (for IF/ICC/IHC).
• High Background: Optimize blocking conditions (increase BSA to 3–5% or add normal goat serum). Increase washing steps and consider using Tween-20 (0.05%) in PBS for stringent washes.
• Photobleaching: Protect samples from light throughout and after staining. Use anti-fade reagents during mounting, especially for prolonged imaging sessions.
• Non-Specific Staining: Titrate antibody concentrations and include isotype controls. For flow cytometry, pre-block with Fc receptor blockers if using leukocytes or other FcR-positive cells.
• Lot-to-Lot Variability: Validate new lots on control samples before use in critical experiments. APExBIO provides detailed QC documentation to support consistency.

For more in-depth troubleshooting strategies and real-world examples, refer to the workflow optimization article—which details solutions to common pain points such as signal drift, background noise, and assay linearity in high-throughput settings.

Future Outlook: Scaling Immunoassay Sensitivity and Multiplexing

As translational immunology and infectious disease research continue to demand higher sensitivity and multiplexing capabilities, the Cy3 Goat Anti-Human IgG (H+L) Antibody is well-positioned to meet these evolving needs. Its robust fluorescence profile, broad compatibility across platforms, and proven reliability empower researchers to translate bench discoveries into actionable diagnostics and therapeutics.

Emerging directions include integrating the Cy3 secondary in digital pathology, single-cell proteomics, and spatial transcriptomics workflows—where precise human immunoglobulin detection is a linchpin for mapping immune landscapes and therapeutic responses. The antibody’s performance in bispecific antibody characterization, as exemplified in the recent orthopoxvirus protection study, underscores its value for both fundamental and applied research.

For deeper mechanistic insights and visionary guidance for next-generation assay development, the article "Illuminating Translational Immunology" extends this discussion, detailing how APExBIO’s Cy3 Goat Anti-Human IgG (H+L) Antibody shapes the future of human IgG detection in translational research.

Summary Table: Quick-Reference Specifications

For ordering information, technical support, or further resources, visit the Cy3 Goat Anti-Human IgG (H+L) Antibody product page or consult APExBIO’s technical literature. Empower your next immunoassay with benchmarked fluorescence, reproducibility, and confidence.